Inhibrx Biosciences Newsroom

Inhibrx: Jury Found in Favor of Inhibrx, Rejecting All Allegations of Misappropriation >INBX

Dow JonesNov 5 06:11

Express News | Inhibrx Biosciences Inc: Legal Victory in a Trade Secrets Case Brought by I-Mab Biopharma

BreakingsNov 5 05:00

Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX)

InvestingSep 13 07:55

Over $7M Bet On This Health Care Stock? Check Out These 3 Stocks Executives Are Buying

BenzingaAug 27 19:10

Inhibrx Biosciences Insider Bought Shares Worth $1,037,328, According to a Recent SEC Filing

MT NewswiresAug 27 04:32

Inhibrx Gains After Insider Purchases From CEO

Seeking AlphaAug 23 22:01

Inhibrx Biosciences, Inc. GAAP EPS of $125.40, Revenue of $100M

Seeking AlphaAug 15 00:36

Earnings Flash (INBX) INHIBRX BIOSCIENCES Posts Q2 Revenue $100,000

MT NewswiresAug 14 17:28

Inhibrx Biosciences Q2 EPS $125.48, Sales $100.00K Up From $30.00K YoY

BenzingaAug 14 15:24

JMP Securities Remains a Hold on Inhibrx Biosciences Inc (INBX)

TipRanksAug 14 12:25

Express News | Inhibrx Biosciences Inc : Jefferies Cuts Target Price to $11 From $35

BreakingsAug 14 11:51

Express News | Inhibrx Inc - Qtrly Shr $125.48

BreakingsAug 14 06:56

Express News | Inhibrx Q2 License Fee Revenue USD 100 Thousand

BreakingsAug 14 06:54

Express News | Inhibrx Q2 Operating Income USD -160.898 Million

BreakingsAug 14 06:54

Express News | Inhibrx Q2 Net Income USD 1,858.011 Million

BreakingsAug 14 06:54

Express News | Inhibrx Q2 Operating Expenses USD 160.998 Million

BreakingsAug 14 06:54

Express News | Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

BreakingsAug 14 06:54

Inhibrx Biosciences 2Q EPS $125.48 >INBX

Dow JonesAug 14 06:54

Inhibrx Biosciences 2Q Rev $100,000 >INBX

Dow JonesAug 14 06:54

Inhibrx Biosciences Reveals Updated Corporate Presentation

TipRanksAug 14 04:42